Clevidipine Patent Expiration
Clevidipine is Used for lowering blood pressure when oral therapy is not feasible or not desirable. It was first introduced by Chiesi Usa Inc
Clevidipine Patents
Given below is the list of patents protecting Clevidipine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Cleviprex | US10010537 | Clevidipine emulsion formulations containing antimicrobial agents | Oct 10, 2031 | Chiesi |
| Cleviprex | US11103490 | Clevidipine emulsion formulations containing antimicrobial agents | Oct 10, 2031 | Chiesi |
| Cleviprex | US5739152 | Pharmaceutical emulsion |
Apr 14, 2015
(Expired) | Chiesi |
| Cleviprex | US5856346 | Short-acting dihydropyridines |
Jan 05, 2021
(Expired) | Chiesi |
| Cleviprex | US5856346 | Short-acting dihydropyridines |
Jan 05, 2021
(Expired) | Chiesi |
| Cleviprex | US8658676 | Clevidipine emulsion formulations containing antimicrobial agents | Oct 10, 2031 | Chiesi |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳